Close

Allergan (AGN) Announces Topline Relamorelin Phase 2b Data; Will Move to Acquire Motus Therapeutics

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/16/2024

1. SPY
2. AMD
3. GS
4. JNJ
5. BAC
6. UNH
7. TSLA
8. MS
9. BK
10. SCHW


Go back to Allergan (AGN) Announces Topline Relamorelin Phase 2b Data; Will Move to Acquire Motus Therapeutics
Allergan Inc (NYSE: AGN) Delayed: 193.02 --0 (-0%)
Previous Close $193.02    52 Week High $322.68 
Open $15.33    52 Week Low $186.34 
Day High $193.02    P/E 45.96 
Day Low $193.02    EPS $4.20 
Volume 43,377